All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BAMBOO HEALTH · Healthcare and prescription drug monitoring

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Kentucky · House · Senate · $80,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 7

HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
S 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
S 2121
SUPPORT for Patients and Communities Reauthorization Act of 2025

Lobbying activity 1

Health Issues

Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.